Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

NCT00832130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2011-12-12

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the clinical utility, safety and effectiveness of the Manual Mini System compared to standardized warm compress therapy for application of controlled, localized heat therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia.

Conditions

  • Chalazion
  • Dry Eye Syndromes

Interventions

DEVICE

Manual Mini System

In-office device treatment for meibomian gland dysfunction by a physician

DEVICE

iHeat Portable Warm Compress Therapy

At-home daily warm compress therapy

Sponsors & Collaborators

  • TearScience, Inc.

    lead INDUSTRY

Principal Investigators

  • Christy Stevens, OD · TearScience, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-06-30
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00832130 on ClinicalTrials.gov